Masahiro Iwasaku

Rebiopsy of non–small cell lung cancer patients with acquired resistance to epidermal growth factor receptor‐tyrosine kinase inhibitor

Akito Hata, Nobuyuki Katakami, Hiroshige Yoshioka et al. · Cancer · 2013 · 178 citations · Full text

Medicine, Molecular Genetics, Oncology +16

ONO-7475, a Novel AXL Inhibitor, Suppresses the Adaptive Resistance to Initial EGFR-TKI Treatment in <i>EGFR</i> -Mutated Non–Small Cell Lung Cancer

Naoko Okura, Naoya Nishioka, Tadaaki Yamada et al. · Clinical Cancer Research · 2020 · 113 citations

Medicine, Oncology, Pharmacology +17

Complex Mutations in the Epidermal Growth Factor Receptor Gene in Non-small Cell Lung Cancer

Akito Hata, Hiroshige Yoshioka, Shiro Fujita et al. · Journal of Thoracic Oncology · 2010 · 97 citations

Medicine, Genetics, Oncology +12

The role of the gut microbiome on the efficacy of immune checkpoint inhibitors in Japanese responder patients with advanced non-small cell lung cancer

Yuki Katayama, Tadaaki Yamada, Takayuki Shimamoto et al. · Translational Lung Cancer Research · 2019 · 92 citations · Full text

Life Sciences, Immunology, Oncology +17

Retrospective Efficacy Analysis of Immune Checkpoint Inhibitor Rechallenge in Patients with Non-Small Cell Lung Cancer

Yuki Katayama, Takayuki Shimamoto, Tadaaki Yamada et al. · Journal of Clinical Medicine · 2019 · 72 citations · Full text

Medicine, Oncology, Cancer Immunology +15